During the second quarter, we sold out four stock positions and added two new ones to the portfolio. Read more here.

Investors also worried about the high valuations of certain AI stocks after double- and triple-digit stock price gains in recent years. Valuations have since come down, and in many cases, they've ...

Reliance's Strand Life Sciences patents a liquid biopsy platform for early cancer detection using AI and cfDNA analysis in ...